JOINTstat
Commercial- Indications
- Rheumatoid arthritis
Company intelligence / Profile preview
Augurex
Vancouver, British Columbia, Canadaaugurex.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Commercial
01
Overview
Augurex is a commercial-stage biotechnology company specializing in the development and commercialization of advanced diagnostic tests for autoimmune conditions. Its flagship product JOINTstat® enables early diagnosis and monitoring of rheumatoid arthritis by detecting the novel biomarker protein 14‑3‑3η. The company also offers SPINEstat®, a first-in-class diagnostic test for axial spondyloarthritis. These solutions are designed to reduce diagnostic delays and improve patient outcomes by enabling timely intervention.
- Therapeutic areas
- RheumatologyImmunology
- Modalities
- Diagnostic test (biomarker-driven diagnostics)Protein biomarker assay (14‑3‑3η protein)Monoclonal antibody-based diagnostic (patent context)
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Quest Diagnostics
Beyond the preview
Go deeper on Augurex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Augurex.